Skip to content
TrustList
BioStar Capital cover

About BioStar Capital

The BioStar team represents a unique collaboration between experienced investment professionals and clinicians with global reputations as medical thought leaders

Innovations with an Impact For over 17 years, BioStar Capital has been at the forefront of transformational medical technology through partnerships with innovative companies

VIEW OUR PORTFOLIO AVS Raises $20 Million in Series B Round to Advance Pulsatile Intravascular Lithotripsy (PIVL) Solutions MMI to Present at the 41st Annual J P Morgan Healthcare Conference BioStar Capital in The Wall Street Journal: Venture Interest in Medical Devices Holds Up, but Investors Are Choosy Medtech Money Podcast, Episode 85: Louis Cannon, Founder & Senior Managing Director at BioStar Capital

SEE MORE OF OUR LATEST NEWS

Categories & features

Ask TrustList to introduce you to BioStar Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of BioStar Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about BioStar Capital.

BioStar Capital alternatives

Similar listings buyers compare against this one.